Subcutaneous recombinant interleukin-2 (rIL-2) in out-patients with metastatic renal cell carcinoma. Results of a multicenter SCAPP1 trial.
Tourani JM, Lucas V, Mayeur D, Dufour B, DiPalma M, Boaziz C, Grise P, Varette C, Pavlovitch JM, Pujade-Lauraine E, Larregain D, Ecstein E, Untereiner M, Vuillemin E, Merran S, Andrieu JM.
Tourani JM, et al. Among authors: varette c.
Ann Oncol. 1996 Jul;7(5):525-8. doi: 10.1093/oxfordjournals.annonc.a010644.
Ann Oncol. 1996.
PMID: 8839910
Free article.
Clinical Trial.